rs587777223
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1PS1_ModeratePM2PP5_Moderate
The NM_024301.5(FKRP):āc.1A>Cā(p.Met1?) variant causes a initiator codon change. The variant allele was found at a frequency of 0.00000138 in 1,452,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ).
Frequency
Genomes: not found (cov: 33)
Exomes š: 0.0000014 ( 0 hom. )
Consequence
FKRP
NM_024301.5 initiator_codon
NM_024301.5 initiator_codon
Scores
8
2
6
Clinical Significance
Conservation
PhyloP100: 5.61
Genes affected
FKRP (HGNC:17997): (fukutin related protein) This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in NM_024301.5 (FKRP) was described as [Pathogenic] in Lovd
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-46755451-A-C is Pathogenic according to our data. Variant chr19-46755451-A-C is described in ClinVar as [Pathogenic]. Clinvar id is 1072163.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FKRP | NM_024301.5 | c.1A>C | p.Met1? | initiator_codon_variant | 4/4 | ENST00000318584.10 | NP_077277.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FKRP | ENST00000318584.10 | c.1A>C | p.Met1? | initiator_codon_variant | 4/4 | 1 | NM_024301.5 | ENSP00000326570.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1452622Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 722732
GnomAD4 exome
AF:
AC:
2
AN:
1452622
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
722732
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Walker-Warburg congenital muscular dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 04, 2022 | This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the FKRP mRNA. The next in-frame methionine is located at codon 144. Disruption of the initiator codon has been observed in individuals with Walker-Warburg syndrome or limb-girdle muscular dystrophy (PMID: 12666124, 20236121). It has also been observed to segregate with disease in related individuals. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Pro89 amino acid residue in FKRP. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16368217, 17446099, 18639457, 18691338). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1072163). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;.;.;.;.;T;.;.;.;.;.;.;.;.;.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
PROVEAN
Benign
.;N;.;.;.;.;N;.;.;.;.;.;.;.;.;.;.;.
REVEL
Pathogenic
Sift
Pathogenic
.;D;.;.;.;.;D;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.;D
Polyphen
0.61
.;P;.;.;.;.;P;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.59, 0.72
MutPred
Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);Loss of MoRF binding (P = 0.0748);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.